Delivra Health Brands Inc. Logo

Delivra Health Brands Inc.

DHBUF

(1.2)
Stock Price

0,01 USD

-9.1% ROA

-19.78% ROE

-12.01x PER

Market Cap.

8.537.222,44 USD

56.58% DER

0% Yield

-5.87% NPM

Delivra Health Brands Inc. Stock Analysis

Delivra Health Brands Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Delivra Health Brands Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's PBV ratio (1.44x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

2 DER

The stock maintains a fair debt to equity ratio (56%), indicating a reasonable balance between the money it owes and the ownership it possesses.

3 Revenue Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

4 Net Profit Growth

With continuous net profit growth in the past three years, this company demonstrates a strong financial performance, making it an enticing investment opportunity.

5 Graham Number

The Graham number of this company suggests that its stock price may be undervalued, indicating a potentially attractive investment opportunity.

6 ROE

The stock's ROE indicates a negative return (-4.99%) on shareholders' equity, suggesting poor financial performance.

7 ROA

The stock's ROA (-2.32%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

8 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

The company's stock appears overvalued (-1) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Delivra Health Brands Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Delivra Health Brands Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Delivra Health Brands Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Delivra Health Brands Inc. Revenue
Year Revenue Growth
2010 0
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 246.699 100%
2017 75.950 -224.82%
2018 725.975 89.54%
2019 11.465.000 93.67%
2020 8.384.000 -36.75%
2021 7.956.000 -5.38%
2022 9.412.000 15.47%
2022 8.139.000 -15.64%
2023 14.684.000 44.57%
2023 9.791.000 -49.97%
2024 12.284.000 20.29%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Delivra Health Brands Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2010 0
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 100.000 100%
2020 179.000 44.13%
2021 72.000 -148.61%
2022 0 0%
2022 352.000 100%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Delivra Health Brands Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2010 54.672
2011 32.859 -66.38%
2012 45.883 28.39%
2013 39.672 -15.66%
2014 36.509 -8.66%
2015 45.967 20.58%
2016 46.253 0.62%
2017 7.033.937 99.34%
2018 10.666.912 34.06%
2019 18.232.000 41.49%
2020 14.203.000 -28.37%
2021 7.885.000 -80.13%
2022 3.896.000 -102.39%
2022 4.894.000 20.39%
2023 3.660.000 -33.72%
2023 4.081.000 10.32%
2024 3.968.000 -2.85%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Delivra Health Brands Inc. EBITDA
Year EBITDA Growth
2010 -54.672
2011 -32.859 -66.38%
2012 -45.883 28.39%
2013 -39.672 -15.66%
2014 -36.509 -8.66%
2015 -45.967 20.58%
2016 -46.253 0.62%
2017 -7.227.204 99.36%
2018 -10.126.996 28.63%
2019 -17.930.000 43.52%
2020 -16.844.000 -6.45%
2021 6.851.000 345.86%
2022 -1.184.000 678.63%
2022 -3.893.000 69.59%
2023 2.416.000 261.13%
2023 -33.000 7421.21%
2024 588.000 105.61%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Delivra Health Brands Inc. Gross Profit
Year Gross Profit Growth
2010 0
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 -951.128 100%
2017 252.371 476.88%
2018 923.818 72.68%
2019 3.008.000 69.29%
2020 -631.000 576.7%
2021 1.919.000 132.88%
2022 3.844.000 50.08%
2022 2.604.000 -47.62%
2023 7.688.000 66.13%
2023 4.823.000 -59.4%
2024 4.856.000 0.68%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Delivra Health Brands Inc. Net Profit
Year Net Profit Growth
2010 -54.672
2011 -32.859 -66.38%
2012 -45.883 28.39%
2013 -39.672 -15.66%
2014 -36.509 -8.66%
2015 -45.967 20.58%
2016 -46.253 0.62%
2017 -8.438.225 99.45%
2018 -12.606.733 33.07%
2019 -27.852.000 54.74%
2020 -79.857.000 65.12%
2021 -28.538.000 -179.83%
2022 -2.740.000 -941.53%
2022 -7.009.000 60.91%
2023 904.000 875.33%
2023 -184.000 591.3%
2024 -1.128.000 83.69%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Delivra Health Brands Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2010 0
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Delivra Health Brands Inc. Free Cashflow
Year Free Cashflow Growth
2010 -19.465
2011 -45.747 57.45%
2012 -44.302 -3.26%
2013 -44.174 -0.29%
2014 -37.137 -18.95%
2015 -44.424 16.4%
2016 -3.044.759 98.54%
2017 -7.341.475 58.53%
2018 -13.805.931 46.82%
2019 -31.226.000 55.79%
2020 -24.674.000 -26.55%
2021 -9.680.000 -154.9%
2022 -4.463.000 -116.89%
2022 -713.000 -525.95%
2023 -1.129.000 36.85%
2023 156.000 823.72%
2024 290.000 46.21%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Delivra Health Brands Inc. Operating Cashflow
Year Operating Cashflow Growth
2010 -19.465
2011 -45.747 57.45%
2012 -44.302 -3.26%
2013 -44.174 -0.29%
2014 -37.137 -18.95%
2015 -44.424 16.4%
2016 -35.304 -25.83%
2017 -4.021.720 99.12%
2018 -11.107.095 63.79%
2019 -19.964.000 44.36%
2020 -18.359.000 -8.74%
2021 -9.647.000 -90.31%
2022 -4.441.000 -117.23%
2022 -713.000 -522.86%
2023 -1.088.000 34.47%
2023 156.000 797.44%
2024 290.000 46.21%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Delivra Health Brands Inc. Capital Expenditure
Year Capital Expenditure Growth
2010 0
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 3.009.455 100%
2017 3.319.755 9.35%
2018 2.698.836 -23.01%
2019 11.262.000 76.04%
2020 6.315.000 -78.34%
2021 33.000 -19036.36%
2022 22.000 -50%
2022 0 0%
2023 41.000 100%
2023 0 0%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Delivra Health Brands Inc. Equity
Year Equity Growth
2010 31.281
2011 185.431 83.13%
2012 139.548 -32.88%
2013 99.876 -39.72%
2014 63.367 -57.62%
2015 67.400 5.98%
2016 21.147 -218.72%
2017 23.121.751 99.91%
2018 104.911.732 77.96%
2019 93.135.000 -12.64%
2020 36.570.000 -154.68%
2021 9.977.000 -266.54%
2022 3.374.000 -195.7%
2022 3.373.000 -0.03%
2023 3.665.000 7.97%
2023 3.389.000 -8.14%
2024 3.558.000 4.75%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Delivra Health Brands Inc. Assets
Year Assets Growth
2010 61.928
2011 203.190 69.52%
2012 158.888 -27.88%
2013 116.226 -36.71%
2014 155.154 25.09%
2015 83.153 -86.59%
2016 47.849 -73.78%
2017 24.123.089 99.8%
2018 109.021.097 77.87%
2019 102.323.000 -6.55%
2020 57.844.000 -76.89%
2021 19.063.000 -203.44%
2022 10.313.000 -84.84%
2022 11.585.000 10.98%
2023 10.815.000 -7.12%
2023 10.563.000 -2.39%
2024 9.313.000 -13.42%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Delivra Health Brands Inc. Liabilities
Year Liabilities Growth
2010 30.647
2011 17.759 -72.57%
2012 19.340 8.17%
2013 16.350 -18.29%
2014 91.787 82.19%
2015 15.753 -482.66%
2016 26.702 41%
2017 1.001.338 97.33%
2018 4.109.365 75.63%
2019 9.188.000 55.27%
2020 21.274.000 56.81%
2021 9.086.000 -134.14%
2022 6.939.000 -30.94%
2022 8.212.000 15.5%
2023 7.150.000 -14.85%
2023 7.174.000 0.33%
2024 5.755.000 -24.66%

Delivra Health Brands Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.04
Net Income per Share
-0
Price to Earning Ratio
-12.01x
Price To Sales Ratio
0.71x
POCF Ratio
-45.9
PFCF Ratio
-38.63
Price to Book Ratio
2.4
EV to Sales
0.59
EV Over EBITDA
2.93
EV to Operating CashFlow
-38.46
EV to FreeCashFlow
-32.37
Earnings Yield
-0.08
FreeCashFlow Yield
-0.03
Market Cap
0,01 Bil.
Enterprise Value
0,01 Bil.
Graham Number
0.02
Graham NetNet
0

Income Statement Metrics

Net Income per Share
-0
Income Quality
0.14
ROE
-0.2
Return On Assets
-0.08
Return On Capital Employed
-0.04
Net Income per EBT
1
EBT Per Ebit
3.49
Ebit per Revenue
-0.02
Effective Tax Rate
-2.78

Margins

Sales, General, & Administrative to Revenue
0.33
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.49
Operating Profit Margin
-0.02
Pretax Profit Margin
-0.06
Net Profit Margin
-0.06

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0
Free CashFlow per Share
-0
Capex to Operating CashFlow
-0.19
Capex to Revenue
0
Capex to Depreciation
0.03
Return on Invested Capital
-0.14
Return on Tangible Assets
-0.09
Days Sales Outstanding
72.86
Days Payables Outstanding
72.79
Days of Inventory on Hand
96.64
Receivables Turnover
5.01
Payables Turnover
5.01
Inventory Turnover
3.78
Capex per Share
0

Balance Sheet

Cash per Share
0,01
Book Value per Share
0,01
Tangible Book Value per Share
0.01
Shareholders Equity per Share
0.01
Interest Debt per Share
0.01
Debt to Equity
0.57
Debt to Assets
0.22
Net Debt to EBITDA
-0.57
Current Ratio
1.91
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
5288000
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.16
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
1699500
Debt to Market Cap
0.24

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Delivra Health Brands Inc. Dividends
Year Dividends Growth

Delivra Health Brands Inc. Profile

About Delivra Health Brands Inc.

Delivra Health Brands Inc. through its subsidiaries, provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. It is involved in selling of cannabis, liquid sleep shots, sleep powder packets, and pain relief creams. The company is headquartered in Vancouver, Canada.

CEO
Mr. Gord Davey
Employee
22
Address
999 Canada Place
Vancouver, V6C 3E2

Delivra Health Brands Inc. Executives & BODs

Delivra Health Brands Inc. Executives & BODs
# Name Age
1 Mr. Gord Davey
President, Chief Executive Officer & Director
70
2 Mr. Matthew Wagar
Senior Vice President of Marketing & Innovation
70
3 Mr. Jack Z. Tasse C.M.A., CPA
Chief Financial Officer & Corporate Secretary
70
4 Mr. Jonathan David Hartshorn
President & Chief Executive Officer of Satipharm
70
5 Mr. Frank A. Holler MBA
Independent Executive Chairman
70
6 Ms. Ann Gallery
Senior Vice President of Corporate Communications
70

Delivra Health Brands Inc. Competitors